Stockscreener 앱 받기
1.17
3.31%
-0.04
시장 영업 전:
1.20
0.03
+2.56%
Mira Pharmaceuticals Inc 주식(MIRA)의 최신 뉴스
International Assets Investment Management LLC Invests $29,000 in MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) - Defense World
MIRA Pharmaceuticals (NASDAQ:MIRA) Shares Down 1.7% – Should You Sell? - Defense World
AMRN Stock Rises Over 5% Amidst Lack of Institutional Ratings - GuruFocus.com
Here's Why We're Not Too Worried About MIRA Pharmaceuticals' (NASDAQ:MIRA) Cash Burn Situation - Yahoo Finance
Zacks Small Cap Has Pessimistic Outlook of MIRA Q4 Earnings - Defense World
Mira Pharmaceuticals appoints new accounting firm By Investing.com - Investing.com South Africa
Mira Pharmaceuticals appoints new accounting firm - Investing.com
Why Wall Street Expects This Growth Stock To Soar 99% In 2025 - Barchart
StatementProposed Amendments To The Air Passenger Protection Regulations - Barchart
Should You Buy Joby Aviation Stock While It's Below $10? - Barchart
C3.ai Stock: Buy, Sell, Or Steer Clear? - Barchart
Is Xcel Energy Stock Underperforming The Nasdaq? - Barchart
2 Fantastic Beaten-Down Growth Stocks Down 35% And 21% To Buy - Barchart
Missed Out on Nvidia: 1 No-Brainer Artificial Intelligence (AI) Stock to Buy Before It Crushes the Market in 2025, and Beyond - Barchart
MIRA Pharmaceuticals Submits IND for Ketamir-2, Targeting Unmet Needs in Neuropathic Pain Treatment - Barchart
MIRA Pharmaceuticals Submits IND for Ketamir-2On December 19, 2024, MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) disclosed that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for Ketamir-2, - Defense World
Stocks In Play: Canacol Energy Ltd. - Barchart
Grain Spreads: Profit Taking Theme - Barchart
Stocks Rally On Dovish PCE Inflation Report - Barchart
The Current State Of HR Is Unacceptable - Barchart
Gilead Stock Gains 15.4% In A Year: Should You Buy, Sell Or Hold? - Barchart
Is Alexandria Real Estate Stock Underperforming The Nasdaq? - Barchart
Is W.R. Berkley Stock Outperforming The Dow? - Barchart
PayPal Rises 40% In A Year: To Buy Or Not To Buy The PYPL Stock? - Barchart
US proposes voluntary guidelines for self-driving vehicles in waning days of Biden administration - Barchart
Takeaways From The Associated Press’ Reporting On Prison Labor In Alabama - Barchart
Arabica Coffee Recovers On Weaker Dollar And Smaller Brazilian Crop - Barchart
Medtronic Stock Declines 5.6% In A Month: Time To Buy The Dip? - Barchart
Is PPG Industries Stock Underperforming The S&P 500? - Barchart
Stocks Regain Footing On Dovish PCE Inflation Report - Barchart
Enterprise Products Stock Rises 25% YTD: Should You Buy Now Or Avoid It? - Barchart
Three Reasons Why PESI Is Risky And One Stock To Buy Instead - Barchart
SCARBOROUGH INNOVATES PARTNERS WITH SUNRAY VENTURE CAPITAL TO ACCELERATE LOCAL STARTUPS WITH 'CATALYST IGNITE' - Barchart
Knightscope K7 Alpha Testing Underway And 2024 Recap - Barchart
Take-Two (NASDAQ:TTWO): Strongest Q3 Results From The Video Gaming Group - Barchart
Stocks Pare Losses on Dovish PCE Report, But Threats Remain from Triple-Witching and Government Shutdown - Barchart
Q3 Video Conferencing Earnings: Five9 (NASDAQ:FIVN) Earns Top Marks - Barchart
3 Reasons To Sell BALY And 1 Stock To Buy Instead - Barchart
Rude Faces Holiday Volatility Amid Fed Policy, G-7 Sanction Talks, And Lower Liquidity - Barchart
Crude Faces Holiday Volatility Amid Fed Policy, G-7 Sanction Talks, And Lower Liquidity - Barchart
2025 Picks: 2 Stocks To Buy Now For 50% Upside - Barchart
Three Reasons Why GPRO Is Risky And One Stock To Buy Instead - Barchart
Beyond Reality: Investing In AR/VR Tech For Future Gains - Barchart
Federal Reserve's Preferred Inflation Gauge Shows Price Pressures Eased Last Month - Barchart
The number of Americans applying for unemployment benefits falls significantly after last week's big jump - Barchart
MIRA Pharmaceuticals Submits IND for Ketamir-2 to FDA, Marking a Significant Milestone in the Company's Pipeline Development - AccessWire
MIRA Pharmaceuticals Submits FDA Application for Breakthrough Pain Treatment Targeting $3.1B Market - StockTitan
3 Best Industrials Sector Picks For Long-Term Investors In 2025 - Barchart
EXCLUSIVE: MIRA Pharmaceuticals Files FDA Application To Start Human Trials For Its Lead Pain Treatment - Benzinga
US stocks fall sharply and Dow tumbles 1,100 points after the Fed hints at just 2 rate cuts for 2025 - Barchart
OUTFRONT Media Stock Rises 33% In 6 Months: Will The Trend Last? - Barchart
Three Reasons To Avoid R And One Stock To Buy Instead - Barchart
Q3 Earnings Highs And Lows: Universal Display (NASDAQ:OLED) Vs The Rest Of The Analog Semiconductors Stocks - Barchart
DocuSign’s New AI-Powered IAM Platform Revitalizes Turnaround - Barchart
Adobe Stock: Buy, Sell, Or Hold After Earnings? - Barchart
Suspect Charged With Killing UnitedHealthcare's CEO As An Act Of Terrorism - Barchart
1 'Strong Buy' Penny Stock With 259% Upside Potential - Barchart
COP's Valuation Looks Attractive: Is It Time To Buy The Stock? - Barchart
4 Big Drug Stocks That May Continue To Outperform In 2025 - Barchart
Will SentinelOne Stock Break Out In 2025? - Barchart
Should You Buy Bitcoin Below $115,000? - Barchart
Retail Sales Rose At Healthy Pace Last Month In Latest Sign Of The US Economy's Health - Barchart
Is Micron Stock A Buy, Sell, Or Hold Before December 18? - Barchart
Nio Might Finally Impress Investors With Growth In 2025 - Barchart
Is Palantir Going To Plunge 50% (or More)? History Offers A Blunt Answer. - Barchart
Should You Buy Palantir Before Dec. 23? - Barchart
Meet the Dow Jones' Top Performing Stock This Year. It's Climbed 2,300% Over the Past 5 Years, and Its Biggest Catalyst May Be Just Ahead. - Barchart
Stock Market Today: Wall Street Trims Its Stellar Gains As Nvidia's Star Dims Again - Barchart
1.22%
1.72%
자본화:
|
볼륨(24시간):